Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessionepkiedthg5hvpadjuh7a23tqcin7tf39): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Objectives: Calcium phosphate (CaP) composites with Ca and P ion release can remineralize tooth lesions and inhibit caries. But the ion release lasts only a few months. The objectives of this study were to develop rechargeable CaP dental composite for the first time, and investigate the Ca and P recharge and re-release of composites with nanoparticles of amorphous calcium phosphate (NACP) to achieve long-term inhibition of caries.
Methods: Three NACP nanocomposites were fabricated with resin matrix of: (1) bisphenol A glycidyl dimethacrylate (BisGMA) and triethylene glycol dimethacrylate (TEGDMA) at 1:1 mass ratio (referred to as BT group); (2) pyromellitic glycerol dimethacrylate (PMGDM) and ethoxylated bisphenol A dimethacrylate (EBPADMA) at 1:1 ratio (PE group); (3) BisGMA, TEGDMA, and Bis[2-(methacryloyloxy)ethyl] phosphate (BisMEP) at 2:1:1 ratio (BTM group). Each resin was filled with 20% NACP and 50% glass particles, and the composite was photo-cured. Specimens were tested for flexural strength and elastic modulus, Ca and P ion release, and Ca and P ion recharge and re-release.
Results: NACP nanocomposites had strengths 3-fold of, and elastic moduli similar to, commercial resin-modified glass ionomer controls. CaP ion recharge capability was the greatest for PE group, followed by BTM group, with BT group being the lowest (p<0.05). For each recharge cycle, CaP re-release reached similarly high levels, showing that CaP re-release did not decrease with more recharge cycles. After six recharge/re-release cycles, NACP nanocomposites without further recharge had continuous CaP ion release for 42 d.
Significance: Novel rechargeable CaP composites achieved long-term and sustained Ca and P ion release. Rechargeable NACP nanocomposite is promising for caries-inhibiting restorations, and the Ca and P ion recharge and re-release method has wide applicability to dental composites, adhesives, cements and sealants to achieve long-term caries-inhibition.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116151 | PMC |
http://dx.doi.org/10.1016/j.dental.2015.11.015 | DOI Listing |
J Mater Sci Mater Med
March 2025
Department of Pre-Clinical Oral Health Sciences, College of Dental Medicine, QU-Health, Qatar University, Doha, Qatar.
Dental calculus, a main contributor of periodontal diseases, is mostly composed of inorganic calcium phosphate species such as dicalcium phosphate, whitlockite, octa calcium phosphate, and hydroxyapatite. Under physiological pH 7.4, dicalcium phosphates can gradually interact with calcium carbonate to form hydroxyapatite.
View Article and Find Full Text PDFBMC Surg
March 2025
Department of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Objective: To evaluate the clinical efficacy of repairing bone defects caused by benign bone tumors using allograft bone combined with calcium phosphate bone powder.
Methods: A retrospective analysis was conducted on 55 patients (aged 10-61 years, mean 35 ± 13.2) with benign bone tumors treated at our hospital from June 2020 to December 2022.
BMC Musculoskelet Disord
March 2025
Department of Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Würzburg, Oberdürrbacherstraße 6, 97080, Würzburg, Germany.
Background: Usually, comminuted fractures contain fragments that are too small for fixation with Kirschner (K)-wires or screws. For those bony or osteochondral fragments, a bone adhesive would be desirable to, for example, enable easy anatomic reduction, avoid discarding of the fragments, and enable temporary fixation to visualize reduction before definitive osteosynthesis is performed. Most of the currently available bone adhesives have shortcomings, such as cytotoxicity, lack of resorbability, and inadequate mechanical properties.
View Article and Find Full Text PDFClin J Am Soc Nephrol
March 2025
Division of Nephrology, Endocrinology, and Metabolism, Tokai University School of Medicine, Kanagawa, Japan.
Background: It is necessary to update the evidence of each phosphate-lowering agent on dialysis patients.
Methods: From the CENTRAL, MEDLINE, EMBASE, and ClinicalTrial.gov databases, randomized controlled trials (RCTs) using oral phosphate-lowering agents on adult patients requiring maintenance dialysis were extracted.
Int Urol Nephrol
March 2025
Mayo Clinic, 200 First St SW, Rochester, MN, 55902, USA.
Objectives: To provide updated population-level data on stone composition by characterizing changes in the prevalence of kidney stone composition by patient age, gender, and geographic location using data from a large tertiary stone analysis laboratory.
Methods: The [redacted for anonymity] receives kidney stone specimens for analysis by infrared spectroscopy. All stones submitted over a 12-month period (December 2022-November 2023) are included in this report.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!